They found that this repression is likely due to the demethylase activity of LSD1, overexpressed in SCLC tumours, which causes the removal of euchromatin marker H3K4me2, suggesting that epigenetic regulation may play an important role in SCLC immunosuppression [68]. The gene discussed is MBD2; the disease is small cell lung carcinoma.